MedPath

Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

Not Applicable
Recruiting
Conditions
Cervical Cancer
Registration Number
NCT05359016
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.

Detailed Description

Objectives:

The study objectives are outlined below:

1. To quantify the health impact of CCS\&PT on the uptake of voluntary FP services.

2. To quantify the health impact of voluntary FP on the uptake of CCS\&PT services.

3. To determine which promotional strategies are most effective to increase uptake of CCS\&PT services.

4. To identify cost to deliver high quality CCS\&PT services integrated into existing voluntary FP programs.

5. To determine client and provider acceptability of integrated CCS\&PT and voluntary FP services using new screen and treat technologies.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
14600
Inclusion Criteria
  • Women 30 - 49 years or all women living with HIV
  • Not currently pregnant
  • Patients with a cervix (women who have undergone a total hysterectomy with removal of the cervix are not eligible)
  • Living in Maputo or Gaza
  • Willing and able to provide informed consent for services.
Exclusion Criteria
  • Not meeting the inclusion criteria
  • Physical or mental impairment that inhibits participation in the study
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of women who will undergo Cervical Cancer Screening by HPV testingthrough study completion, an average of 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

M D Anderson Cancer Center

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

M D Anderson Cancer Center
πŸ‡ΊπŸ‡ΈHouston, Texas, United States
Kathleen Schmeler, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.